Notably, miR-9 targets other than E-cadherin may affect OCCC oncogenesis, thus warranting additional studies to explore possible roles for miR-9 upregulation and define the molecular mechanisms involved in the pathogenesis of this specific type of ovarian cancer. The gene discussed is CDH1; the disease is ovarian carcinoma.